EUVIMEDEUVIMED entdecken
Open Access

Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular Events

Rachel A Myers iD, Thomas L Ortel iD, Alexander Waldrop iD, MacIntosh Cornwell iD, Jonathan D Newman iD, Natalie K Levy, Tessa J Barrett iD, Kelly Ruggles iD, Marcin A Sowa iD, Sandeep Dave, Geoffrey S Ginsburg iD, Jeffrey S Berger iD und 1 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2024

DOI: 10.1161/atvbaha.123.319759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Rachel A Myers und 12 weiteren Autor:innen. Beteiligte Einrichtung: Duke Clinical Research Unit, Duke University School of Medicine, Durham NC (R.A.M.). Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Acute Coronary Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Identifying patients with the optimal risk:benefit for ticagrelor is challenging. The aim was to identify ticagrelor-responsive platelet transcripts as biomarkers of platelet function and cardiovascular risk. METHODS: Healthy volunteers (n=58, discovery; n=49, validation) were exposed to 4 weeks of ticagrelor with platelet RNA data, platelet function, and self-reported bleeding measured pre-/post-ticagrelor. RNA sequencing was used to discover platelet genes affected by ticagrelor, and a subset of the most informative was summarized into a composite score and tested for validation. This score was further analyzed (1) in CD34+ megakaryocytes exposed to an P2Y12 inhibitor in vitro, (2) with baseline platelet function in healthy controls, (3) in peripheral artery disease patients (n=139) versus patient controls (n=30) without atherosclerosis, and (4) in patients with peripheral artery disease for correlation with atherosclerosis severity and risk of incident major adverse cardiovascular and limb events. RESULTS: Ticagrelor exposure differentially expressed 3409 platelet transcripts. Of these, 111 were prioritized to calculate a Ticagrelor Exposure Signature score, which ticagrelor reproducibly increased in discovery and validation cohorts. Ticagrelor’s effects on platelets transcripts positively correlated with effects of P2Y12 inhibition in primary megakaryocytes. In healthy controls, higher baseline scores correlated with lower baseline platelet function and with minor bleeding while receiving ticagrelor. In patients, lower scores independently associated with both the presence and extent of atherosclerosis and incident ischemic events. CONCLUSIONS: Ticagrelor-responsive platelet transcripts are a biomarker for platelet function and cardiovascular risk and may have clinical utility for selecting patients with optimal risk:benefit for ticagrelor use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseAcute Coronary SyndromeHumansTicagrelorPlatelet Aggregation InhibitorsClopidogrelPurinergic P2Y Receptor AntagonistsAdenosineHemorrhageBiomarkersTreatment Outcome

Stichwörter der Autor:innen

biomarkersheart disease risk factorshemorrhageplatelet aggregation inhibitorprecision medicine

Substanzen

TicagrelorPlatelet Aggregation InhibitorsClopidogrelPurinergic P2Y Receptor AntagonistsAdenosineBiomarkers

Autor:innen und Institutionen

  • Duke Clinical Research Unit, Duke University School of Medicine, Durham NC (R.A.M.).
  • Departments of Medicine, Duke University Medical Center, Durham NC (T.L.O., A.W., S.D., D.V.).
  • Center for Genomics and Computational Biology, Duke University, Durham, NC (A.W., S.D.).
  • NYU Grossman School of Medicine, Leon H. Charney Division of Cardiology (M.C., J.D.N., N.K.L., T.J.B., K.R., M.A.S., J.S.B.).
  • All of Us Research Program, National Institutes of Health, Bethesda, MD (G.S.G.).

ORCID-Profile: Rachel A Myers, Thomas L Ortel, Alexander Waldrop, MacIntosh Cornwell, Jonathan D Newman, Tessa J Barrett, Kelly Ruggles, Marcin A Sowa, Geoffrey S Ginsburg, Jeffrey S Berger, Deepak Voora

Förderung

  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • NCBDD CDC HHS
  • NIGMS NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Myers, R. A., Ortel, T. L., Waldrop, A., Cornwell, M., Newman, J. D., Levy, N. K., Barrett, T. J., Ruggles, K., Sowa, M. A., Dave, S., Ginsburg, G. S., Berger, J. S., & Voora, D. (2024). Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular Events. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.319759

Vancouver

Myers RA, Ortel TL, Waldrop A, Cornwell M, Newman JD, Levy NK, et al. Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular Events. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.123.319759

BibTeX
@article{Myers2024,
  author = {Myers, Rachel A and Ortel, Thomas L and Waldrop, Alexander and Cornwell, MacIntosh and Newman, Jonathan D and Levy, Natalie K and Barrett, Tessa J and Ruggles, Kelly and Sowa, Marcin A and Dave, Sandeep and Ginsburg, Geoffrey S and Berger, Jeffrey S and Voora, Deepak},
  title = {Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular Events},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2024},
  doi = {10.1161/atvbaha.123.319759}
}
Kostenlos starten →